4Buse DC,Lipton RB.Facilitating communication with patients for improved migraine outcomes[J].Curr Pain Headache Rep,2008,12(3):230-236. 被引量：1
5Chozzi H,Kassis M,Hakim A,et al.Medication adherence of a sample of hypertensive patients in the region of Sfax(Tunisia)[J].Ann Cardiol Angeioi(Paris),2010,59(3):131-137. 被引量：1
6MacGregor EA.The doctor and the migraine patient:improving compliance[J].Neurology,1997,48(Suppl 3):16-20. 被引量：1
7Domenico D'Amico,Stewart J Tepper.Prophylaxis of migraine:general principles and patient acceptance[J].Neuropsychiatric Disease and Treatment,2008,4(6):1155-1167. 被引量：1
8Massiou H.Migraine medication attributes are important for patient compliance.Drugs Today.(Barc).2003,39(4):25-29. 被引量：1
10Rozen TD.Migraine prevention:what patients want from medication and their physicians (a headache specialty clinic perspective).Headache,2006,46:750-753. 被引量：1
6WHO. Adherence to long-term therapies: evidence for action. Geneva: WHO, 2003. 被引量：1
7Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. JAIDS ,2002,31 : 103-106. 被引量：1
8Marie KW, Sheila T, Paul M, et al. Medication adherence : a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin in Cardiol,2004,19:357-362. 被引量：1
9Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence. Medical Care, 2004, 42:649-652. 被引量：1
10Evangelista LS. Compliance behavior of elderly patients with advanced heart failure. J Cardiovasc Nus, 2003,18:197-206. 被引量：1
